On July 31, 2025, the United States Department of Justice (DOJ) announced a $9.8 million settlement with Illumina, Inc. (Illumina) to resolve alleged False Claims Act (FCA) violations related to cybersecurity vulnerabilities and shortcomings in its genomic sequencing products. Of the total settlement, $1.9 million will be paid to the qui tam whistleblower who brought the FCA case—Illumina’s former Director of Platform Management….
By: Alston & Bird
By: Alston & Bird
